Table 4.

Associations of baseline miRNA expression and clinico-pathologic parameters with disease free and overall survival

	Disease free survival [months]	p	Overall survival [months]	p
miR-200c High (≥0.85; n=32)	67	0.03	99	0.02
Low (<0.85; n=32)	101		115
miR-155 High (>1.0; n=32)	60	<0.01	89	0.03
Low (<1.0; n=32)	104		117
Estrogen Receptor Positive (n=41)	94	<0.01	115	0.03
Negative (n=23)	60		81
Grade 2 (n=17)		>0.1	124	0.04
3 (n=47)			95
ypN 0 (n=26)		>0.1	125	0.01
≥1 (n=38)			90
pCR (n=9)	99	>0.1	124	>0.1
non-pCR (n=55)	77	0.07	99	0.09

High, relative miRNA expression above the median value

Low, relative miRNA expression below the median value

p, two-sided level of significance assessed by log-rank test